Amanta Healthcare Intrinsic Value
Amanta Healthcare (AMANTA) median intrinsic value is ₹95.26 from 9 valuation models (range ₹47–₹148), vs current price ₹157.14 — -39.4% downside (Trading Above Calculated Value), margin of safety -65.0%. For current market price and key ratios, visit Amanta Healthcare share price today.
AMANTA Valuation Methods Summary — DCF, Graham Number & P/E
Amanta Healthcare intrinsic value across 9 models vs current price ₹157.14 — upside/downside and value range per method. Analyse Amanta Healthcare ownership structure to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹95.26 | ₹76.21 - ₹114.31 | -39.4% | EPS: ₹4.33, Sector P/E: 22x |
| Book Value Method | asset | ₹112.82 | ₹101.54 - ₹124.10 | -28.2% | Book Value/Share: ₹56.41, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹147.69 | ₹132.92 - ₹162.46 | -6.0% | Revenue/Share: ₹73.85, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹146.15 | ₹131.53 - ₹160.77 | -7.0% | EBITDA: ₹57.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹140.72 | ₹112.58 - ₹168.86 | -10.4% | CF Growth: 11.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹47.14 | ₹42.43 - ₹51.85 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹66.94 | ₹60.25 - ₹73.63 | -57.4% | Revenue Growth: 6.1%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹78.57 | ₹70.71 - ₹86.43 | -50.0% | ROE: 5.9%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹74.13 | ₹66.72 - ₹81.54 | -52.8% | EPS: ₹4.33, BVPS: ₹56.41 |
AMANTA Intrinsic Value vs Market Price — All Valuation Models
Amanta Healthcare fair value range ₹47–₹148 vs current market price ₹157.14 across 9 valuation models. Read AMANTA dividend history for the complete payout history and dividend yield track record.
AMANTA Intrinsic Value Analysis — Undervalued or Overvalued?
Amanta Healthcare median intrinsic value ₹95.26, current price ₹157.14 — Trading Above Calculated Value by 39.4%, margin of safety -65.0%.
What is the intrinsic value of AMANTA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Amanta Healthcare (AMANTA) is ₹95.26 (median value). With the current market price of ₹157.14, this represents a -39.4% variance from our estimated fair value.
The valuation range spans from ₹47.14 to ₹147.69, indicating ₹47.14 - ₹147.69.
Is AMANTA undervalued or overvalued?
Based on our multi-method analysis, Amanta Healthcare (AMANTA) appears to be trading above calculated value by approximately 39.4%.
AMANTA Financial Health — Key Ratios vs Industry Benchmarks
Amanta Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.21 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 5.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.52x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
AMANTA Cash Flow Quality — Operating & Free Cash Flow
Amanta Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹47 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹58 Cr | ₹53 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹43 Cr | ₹40 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹62 Cr | ₹59 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹31 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |